GENT yields 4.19% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, GENT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GENT + JNJ for your $10,000?
GENT actively invests in taxable fixed income securities both issued by US and domestic entities. These securities include US Treasurys, TIPS, US mortgage- and asset-backed securities, government debt, corporate bonds, preferred securities, floating rate notes, and agency bonds. The fund focuses on investment grade, intermediate-term debt, all with a weighted average duration equal to 150% of the Bloomberg Intermediate US Gov/Credit Index. Selection of constituents is based on a thorough review of macroeconomic data, interest rate patterns, and yield curve dynamics. Fundamental analysis with quantitative techniques is also utilized to mitigate risks. It is expected for the subadvisor to actively adjust the funds average maturity and duration to achieve its objective of maximum current income and strong total return potential in all market cycles.
Full GENT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.